Mount Laurel, NJ (February 22, 2021)  PMC Group International, Inc., which is an independent arm of PMC Group Companies, announced the acquisition of Cobra Investments Management Inc. and its two subsidiaries, Copperhead Chemical Company Inc. (“Copperhead”) and Copperhead Investments Inc., from a group of previous owners of these entities, effective February 5, 2021. Copperhead is

Mount Laurel, NJ (December 9, 2020) PMC Organometallix Inc., a wholly owned subsidiary of PMC Group N.A., Inc. is pleased to confirm that, despite challenges presented by the global pandemic, it has embarked on, and will continue with plans to expand capacity for production of organotin intermediates at Axis, AL and for organotin catalysts at

MEMPHIS, TN (November 13, 2020) — PMC Biogenix Inc. announces that effective December 1, 2020 or as otherwise consistent with current written contracts, prices for products sold under the trademarks Armoslip®, Hystrene®, Industrene®, Kemamide®, Kemester®, and Lubrazinc® will be increased by 5 – 15% depending upon grade. Customers with questions should contact their sales manager for

Mount Laurel, NJ (January 2, 2020) — PMC Group N.A., Inc. (“PMC”) and Lanxess Organometallics GmbH (“Lanxess”) have announced that PMC has acquired Lanxess’ organotin specialties product line (the “Business”). The transaction, previously reported on November 13, 2019, has closed effective December 30, 2019. The Business included Lanxess’ global organotin catalyst, organotin specialties and intermediates product